BeOne Medicines
ONC
#621
Rank
NZ$64.99 B
Marketcap
NZ$587.38
Share price
1.62%
Change (1 day)
48.84%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): NZ$0.98

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$1.08. In 2024 the company made an earnings per share (EPS) of NZ-$10.41.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.98-109.38%
2024NZ-$10.41
2022NZ-$32.5428.21%
2021NZ-$25.38-19.96%
2020NZ-$31.7120.81%
2019NZ-$26.2531.52%
2018NZ-$19.96417.57%
2017NZ-$3.86-37.16%
2016NZ-$6.14158.95%
2015NZ-$2.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.40-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.59-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA